LY294002 化学構造
分子量: 307.34




Quality Control & MSDS


  • Compare PI3K Inhibitors
  • 研究分野
  • LY294002のメカニズム



製品説明 LY294002は、p110α、p110δとp110βのPI3K阻害剤で、IC50 がそれぞれ 0.5 μM、0.57 μM、0.97 μMです。
ターゲット p110α p110δ p110β
IC50 0.5 μM 0.57 μM 0.97 μM[1]
In vitro試験 LY294002 inactivates Akt/PKB, consequently inhibiting cell proliferation and inducing apoptosis. LY294002 demonstrates a remarkable growth-inhibitory and apoptosis-inducing effect in these colon cancer cell lines, with decreased expression of phosphorylated Akt (Ser473). [2]LY294002 induces marked nuclear pyknosis and diminished cytoplasmic volume in the tumor cells. Thus, LY294002 markedly inhibits ovarian cancer cell proliferation in vitro. LY294002 induces specific G1 arrest in cell growth, leading to almost complete inhibition of melanoma cell proliferation and partial inhibition of MG-63 (osteosarcoma cell line) proliferation. The effect of LY294002 on cell cycle progression may provide insights into a possible link between the PI3K activation pathway and cancer cell cycle regulation. [3]
In vivo試験 LY294002 also results in suppression of tumor growth and induction of apoptosis, especially in the LoVo tumors, and therefore shows remarkable effectiveness in the mouse peritonitis carcinomatosa model. [2] LY294002 significantly inhibits growth and ascites formation of ovarian carcinoma. [3]
臨床試験 LY294002 is currently in Phase I clinical trials in patients with cancers.

プロトコル (参考用のみ)

キナーゼアッセイ: [4]

kinase assays PI3K inhibition by LY294002 is determined in a radiometric assay using purified, recombinant enzymes with 1 μM ATP. The kinase reaction is carried out for 1 hour at room temperature (24oC) and is terminated by addition of PBS. IC50 values are subsequently determined using a sigmoidal dose–response curve fit (variable slope). CK2 and GSK3β (glycogen synthase kinase 3β) inhibition is established by kinase selectivity screening. LY294002 is tested against the Upstate panel of kinases in 10 μM ATP.

細胞アッセイ: [2]

細胞株 Colon cancer cell lines DLD-1, LoVo, HCT15, and Colo205
濃度 0–50 μM
反応時間 0–48 hours
実験の流れ 1.0×105 cells (100 μL volume/well) are inoculated into 96-well microtiter plates. LY294002 is added to triplicate wells and cultured at 37oC for 0–48 hours. After treatment, 10 μL of Premix WST-1 are added to each microculture well, and the plates are incubated for 60 minutes at 37oC, after which absorbance at 450 nm is measured with a microplate reader.

動物実験: [3]

動物モデル Two groups of athymic nude mice (5–7 weeks) are inoculated i.p. with OVCAR-3 cells
製剤 Dissolved in DMSO plus 0.25 ml of PBS
投薬量 0–100 mg/kg
投与方法 Administered via i.p.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDogMonkeyBaboon
Weight (kg)
Body Surface Area (m2)0.0070.0250.
Km factor361285201220
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)



Download LY294002 SDF
分子量 307.34


CAS No. 154447-36-6
保管 2年-20℃
6月-80℃in solvent
別名 SF 1101, NSC 697286
溶解度 (25°C) * In vitro DMSO 36 mg/mL (117.13 mM)
エタノール 21 mg/mL (68.32 mM)
<1 mg/mL (<1 mM)
In vivo 2% DMSO/30% polyethylene glycol/1% Tween 80 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 2-morpholino-8-phenyl-4H-chromen-4-one

カスタマーフィードバック (13)

Click to enlarge
Source Hepatology, 2014, 59(4), 1262-72. LY294002 purchased from Selleck
Method Immunoblot analysis
Cell Lines Huh7 cells
Incubation Time 6 h
Results Ly294002, SB203580, rottlerin, PD98059, and SP600125 were applied to Huh7 cells to specifically inhibit the activities of p38 MAPK, PKC-d, PI3K, MEK, and JNK, respectively, and the cells were subsequently stimulated with either IFN-a or IFN-b for the next 6 hours. Overall, PKC-d was found to be primarily responsible for S727 phosphorylation in the signaling pathways of both type I IFNs, with the kinase inhibitor rottlerin blocking a majority of the serine phosphorylation after 6 hours of stimulation.

Click to enlarge
Source Clin Cancer Res, 2011, 17, 7116-7126. LY294002 purchased from Selleck
Method Western blot
Cell Lines FaDu cells
Concentrations 20 μmol/L
Incubation Time 0-30 min
Results Both BGT226 and LY294002 attenuated p-AKT and p-p70 Thr389 expression after short-term treatment, whereas rapamycin diminished the phosphorylation of p70S6K but not AKT.

Click to enlarge
Source Oncogene, 2012, 31, 3277–3286. LY294002 purchased from Selleck
Method Western Blot
Cell Lines HEK-293 cells
Concentrations 30 uM
Incubation Time
Results We cultured HEK-293 cellsstably overexpressing p37d or p110d with the general PI3K –inhibitor, LY294002, or the MAPK-inhibitor, AZD6244. The inhibitors strongly affected the levels ofphosphorylated AKT S473 and ERK.

Click to enlarge
Source Sci Rep, 2015, 5, 11634. LY294002 purchased from Selleck
Method Western blotting assays
Cell Lines NCI-N87/TR cells
Concentrations 1 uM
Incubation Time 24 h
Results After cells were incubated with the PI3K inhibitor LY294002, as well as transfected with siRNA targeting PI3Kp110, western blotting showed that the P-AKT protein expression decreased in both NCI-N87 and NCI-N87/TR cells(both P= 0.000), and the descent of AKT protein phosphorylation indicating that the inhibitor LY294002 effectively blocked the PI3K-AKT signaling pathway.

Click to enlarge
Source Mol Oncol, 2013, 7, 359-68. LY294002 purchased from Selleck
Method Xenograft
Cell Lines SCC61, Detroit 562
Concentrations 100 mg/kg
Incubation Time 20 day
Results In female nude mice injected with SCC61 or Detroit 562 cells, both gefitinib and LY294002 inhibited tumor growth (Figure 5). However, the most effective way to inhibit tumor growth in EGFR resistant cell line tumors in vivo was to block both EGFR and PI3K activity with gefitinib and LY294002.

Click to enlarge
Source Mol Oncol, 2013, 7, 359-68. LY294002 purchased from Selleck
Method Cell growth inhibition assay with MTT
Cell Lines SQ20B/SCC61/SCC35/SCC25/HN31/MSK921/Detroit 562/HN5 cell
Concentrations 10 uM
Incubation Time 4 h
Results LY294002 effectively reduced cell viability while the combination of LY294002 and gefitinib had an additive effect (Figure A).

Click to enlarge
Source Br J Pharmacol, 2013, 70(5), 1137-51. LY294002 purchased from Selleck
Method Immunofluorescence
Cell Lines MCF-7 FLV1000 cells
Concentrations 2/4 uM
Incubation Time 16 h
Results The involvement of PTEN/PI3K/Akt pathway in the internalization of ABCG2 by PPARγ agonists was further examined by the use of PI3K inhibitor (LY294002). As illustrated in Figure, treatment of MCF-7 FLV1000 by LY294002 for 16 h was found to cause concentration-dependent translocation of ABCG2 from plasma membrane to the subcellular compartment, mirroring the effect of the three PPARγ agonists.

Click to enlarge
Source Hum Reprod, 2015, 30(2), 284-98. LY294002 purchased from Selleck
Method Immunofluorescence
Cell Lines Blastocysts
Concentrations 5 uM
Incubation Time 24, 48, 72 h
Results Day 5 blastocysts were cultured in SS medium in the presence or absence of 10 ng/ml IGF1 and collected at 24, 48 and 72 h and then immunostained for fibronectin. At 24 h (now day 6 blastocyst), fibronectin was located in the cytoplasm, nucleus, cell–cell junctions and on the basal and apical surface of the cells in the trophectoderm (A and B). The ICM also expressed fibronectin but this was restricted to the cells facing the blastocoel. IGF1 treatment had no effect on fibronectin localization or staining intensity at 24 h. IGF1 treatment increased fibronectin staining intensity at 48 h compared with the SS control (C versus D). The localization at 48 h was comparable between the SS control and IGF1 group. At 72 h (Day 8 blastocyst), there was a distinct polarization of fibronectin in the trophectoderm on one side of the blastocyst and the localization was cytoplasmic and punctate. There was no staining in the ICM (E and F). At 72 h in the IGF1 treated group, fibronectin staining was of a much higher intensity, compared with the SS group (E versus F). The addition of the PI3 kinase inhibitor, 5 mM LY294002, to IGF1 treated blastocysts affected the overall polarization of fibronectin and compared with the intense apical staining seen in IGF1 treated blastocysts the localization of fibronectin in LY294002 treated blastocysts in the presence of IGF1, was more cytoplasmic and strong staining in the cell-cell junctions was present.

Click to enlarge
Source Int J Biochem Cell Biol, 2015, 60, 34-42. LY294002 purchased from Selleck
Method Western blot
Cell Lines A549 cells
Concentrations 20 uM
Incubation Time 1 h
Results Treatment of A549 cells with PI3K inhibitor LY294002 or BKM120 completely abolished the increase of the S6K1 and its downstream S6 phosphorylation exposed to Kb and subsequently challenged with PMA for 1 h and 2 h.

Click to enlarge
Source 2010, Saraswati Sukumar of Johns Hopkins University School of Medicine. LY294002 purchased from Selleck
Method Western blot
Cell Lines T47D cells
Incubation Time 1 h
Results Reduction of AKT phosphorylation in T47D cells treated with LY294002 was observed.

Click to enlarge
Source 2010, Dr. Zhang of Tianjin Medical University. LY294002 purchased from Selleck
Method Western blot
Cell Lines T47D cells
Concentrations 0.1-20 μM
Incubation Time 24 h
Results Reduction of AKT phosphorylation in T47D cells treated with LY294002 was observed.

Click to enlarge
Source Biochim Biophys Acta, 2012, 1823(5), 987-96. LY294002 purchased from Selleck
Method Immunofluorescence
Cell Lines HC11 cells
Concentrations 50 μM
Incubation Time 1 h
Results whole ADRP levels, estimated by Western blot , decreased only in the presence of MK -2206 and LY294002. In most cases, ADRP decorated the surface of small lipid droplets and appeared as little patches on large cytoplasmic lipid droplets. With the exception of SP600125, which induced a strong ADRP coating of almost all cytoplasmic lipid droplets (although this inhibitor did not increase ADRP synthesis), variation in the distribution of ADRP at the surface of lipid droplet was difficult to estimate, notably because the signal was faint and uneven.

Click to enlarge
Source Biochim Biophys Acta, 2012, 1823(5), 987-96. LY294002 purchased from Selleck
Method Western blot
Cell Lines HC11 cells
Concentrations 50 μM
Incubation Time
Results Addition of 50μM LY294002, a PI3-kinase inhibitor with higher stability and specificity provoked the complete arrest of PRL-induced β-casein synthesis and a drastic inhibition of that of ADRP.

文献中の引用 (66)



電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related PI3K 阻害剤

  • GDC-0032

    GDC-0032 is a potent, next-generation PI3K inhibitor targeting PI3K alpha.

    Features:A beta isoform-sparing PI3K inhibitor.

  • Pilaralisib (XL147)

    Pilaralisib (XL147) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ with IC50 of 39 nM/36 nM/23 nM in cell-free assays, less potent to PI3Kβ. Phase 1/2.

  • GNE-317

    GNE-317 is a potent, brain-penetrant PI3K inhibitor.

  • PI-3065

    PI-3065 is a selective p110δ inhibitor with IC50 of 15 nM, >70-fold selectivity over other PI3K family members.

  • 3-Methyladenine (3-MA)

    3-Methyladenine (3-MA) は選択の自噬とリン酸イノシトール3キナーゼ(キナーゼ)阻害剤、Vps34 と PI3Kγ に作用する時、 IC50 がそれぞれ 25 nM と 60 nM になる。自動食物胞の形成を妨害すること。

  • CAL-101 (Idelalisib, GS-1101)

    CAL-101 (Idelalisib, GS-1101)は、2.5nMのIC50によるp110δの選択的なPI3KクラスI阻害剤です。

  • Wortmannin


  • BEZ235 (NVP-BEZ235, Dactolisib)

    BEZ235 (NVP-BEZ235, Dactolisib)は競争性的なPI3K、mTOR 阻害剤、 p110α, p110γ, p110δ と p110β を作用すると、 IC50 がぞれぞれ 4 nM, 5 nM, 7 nM と 75 nMになる.

  • BKM120 (NVP-BKM120, Buparlisib)

    BKM120 (NVP-BKM120, Buparlisib)は、p110α、p110β、p110δとp110γの選択的なPI3K阻害剤で、IC50 がそれぞれ 52-99 nM、166 nM、 116 nM、 262 nMです。


Tags: LY294002を買う | LY294002供給者 | LY294002を購入する | LY294002費用 | LY294002生産者 | オーダーLY294002 | LY294002代理店
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID